Zai Lab Ltd. (9688)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about Zai Lab Ltd. (9688)
Company Performance

Current Price

as of Oct 16, 2024

$2.50

P/E Ratio

N/A

Market Cap

$2.49B

Description

Zai Lab Ltd. is a biopharmaceutical company, which engages in the developing and commercializing therapies that address medical conditions with unmet needs in oncology, autoimmune disorders, infectious diseases, and neuroscience. Its products include Zejula, Optune, Qinlock, and Nuzyra. The company was founded by Samantha Ying Du and Marietta Wu in April 2014 and is headquartered in Shanghai, China.

Metrics

Overview

  • HQShanghai, SH
  • SectorHealth Technology
  • IndustryBiotechnology
  • Ticker9688
  • Price$2.503931+3.12%

Trading Information

  • Market Cap$2.49B
  • Float89.91%
  • Average Daily Volume (1m)5,207,812
  • Average Daily Volume (3m)3,420,473
  • EPS-$2.40

Company

  • Revenue$2.52B
  • Rev Growth (1yr)45.55%
  • Net Income-$627.59M
  • Gross Margin64.94%
  • EBITDA Margin-70.69%
  • EBITDA-$555.46M
  • EV$8.03B
  • EV/Revenue3.18
  • P/EN/A
  • P/S7.53
  • P/B3.47
Documents